Clinical TrialsSearch results
Number of results: 757
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Completed
- Phase I Clinical Study of S-001000 Multiple Doses(twice-daily oral administration)
- Gout and Hyperuricemia
- Tsubouchi Ichiro
- 2021-11-05
Recruiting
- A Single and Multiple Dose Study of DSP-9632P
- Levodopa-induced dyskinesia in Parkinson's disease
- Nakamura Hiroki
- 2021-10-30
Other
- A Phase 2 study to assess the safety, immunogenicity and recommended dose of DS-5670a in Japanese healthy adults
- Prevention of infectious disease by Severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)
- Inoguchi Akihiro
- 2021-10-29
Recruiting
- A Phase 3, Multicenter, Open-Label, Long-Term Trial to Evaluate the Safety and Efficacy of Efgartigimod (ARGX 113) PH20 Subcutaneous in Adult Patients With Primary Immune Thrombocytopenia
- Primary Immune Thrombocytopenia
- Gandini Domenica
- 2021-10-29
Recruiting
- A multicenter phase II study to evaluate the efficacy and safety of fixed-duration sequential treatment combined with novel agents and autologous stem cell transplantation for newly diagnosed elderly multiple myeloma. -JSCT EMM21-
- Multiple myeloma
- Kikushige Yoshikane
- 2021-10-26
Completed
- Clinical pharmacology study of K-237
- COVID-19
- Tanigawa Ryohei
- 2021-10-26
Other
- A Study of JNJ-75105186 in Healthy Japanese and Chinese Participants
- Healthy
- Nakano Masayoshi
- 2021-10-22
Other
- Multicenter, open-label, uncontrolled study to evaluate the safety and immunogenicity of KD-414, a vaccine against COVID-19, in healthy Japanese subjects aged 18 years or older.
- Prevention of COVID-19
- Matsumoto Takayuki
- 2021-10-22
Recruiting
- Phase I / II Clinical Trial of GAIA-102 for advanced and relapse NSCLC
- advanced and relapse NSCLC
- Okamoto Isamu
- 2021-10-19
Other
- A Study of JNJ-77242113 in Healthy Japanese and Chinese Participants
- Healthy
- Nakano Masayoshi
- 2021-10-18